Webinar ：Implementation of Digital PCR in a Molecular Diagnostic Laboratory: Evaluation of Minimal Residual Disease

Genomeweb will give a webinar on September 25th at 23:00 GMT (Paris time: 17:00) with a presentation by Dr. Benjamin Tournier, the School of Molecular Pathology, National Dijon University Hospital, France. In the Molecular Pathology department of the Dijon University Hospital, liquid biopsy analyses were set up since March 2016. Here we present the implementation of the 3-color Crystal Digital PCR system in our laboratory for the management of melanoma and lung cancer patients under targeted therapy.

Click on the link to register for registration:

https://genomeweb.webex.com/genomeweb/onstage/g.php?MTID=e3cc7d08f97d92545db7e2fa5799f3a4c&sourceid=stillalp

Presenter introduction：

After completing a molecular biology thesis about genetic and epigenetic alterations in stage II colon cancers, Benjamin started working on liquid biopsy pre-analytics and analyses in 2016, in the molecular pathology department of the Dijon University Hospital, France. He is particularly involved in digital PCR assays development and he recently graduated with a degree in NGS bioinformatic data analysis.

Abstract:

• Understanding the liquid biopsy process for metastatic melanoma (BRAF mutations) and lung cancer (EGFR mutations) patients

• Understanding the Naica System workflow and its advantages

• Digital PCR for the detection of circulating tumor DNA, circulating tumor cells and circulating tumor exosomes in liquid biopsy

• Digital PCR as a particularly adapted technique for monitoring patients and their treatment (immunotherapy)